Literature DB >> 15781261

HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells.

Keiko Sekine1, Yanyan Hao, Yasuyuki Suzuki, Ryosuke Takahashi, Takashi Tsuruo, Mikihiko Naito.   

Abstract

Apollon/BRUCE is a giant IAP protein that has BIR and UBC domains in its amino- and carboxy-terminals, respectively. Apollon binds and ubiquitylates SMAC/DIABLO and caspase9, and regulates apoptosis by facilitating proteasomal degradation of these proteins. Apollon overexpression inhibits apoptosis, while its downregulation sensitizes cells to apoptosis, suggesting that Apollon level is important for apoptosis regulation. Here we show that HtrA2/Omi catalytically cleaves Apollon with its serine protease activity. Conversely, Apollon ubiquitylates and facilitates proteasomal degradation of HtrA2 that binds to Apollon through IAP-binding motif. Thus, Apollon and HtrA2 mutually downregulate each other. Expression of catalytically active, but not inactive, HtrA2 induced apoptosis in Apollon-expressing cells. In Apollon-deficient cells, however, expression of catalytically inactive HtrA2 mutant with IAP-binding motif also induced apoptosis. These results indicate that HtrA2 induces apoptosis in two different mechanisms, one with serine protease domain and the other with IAP-binding motif, in Apollon-deficient cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781261     DOI: 10.1016/j.bbrc.2005.02.165

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.

Authors:  Meenakshi P Balakrishnan; Lucia Cilenti; Zineb Mashak; Paiyal Popat; Emad S Alnemri; Antonis S Zervos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

2.  APOLLON protein promotes early mitotic CYCLIN A degradation independent of the spindle assembly checkpoint.

Authors:  Ryo Kikuchi; Hirokazu Ohata; Nobumichi Ohoka; Atsushi Kawabata; Mikihiko Naito
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

3.  Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents.

Authors:  Jason B Garrison; Chunmin Ge; Lixiao Che; Derek A Pullum; Guang Peng; Sohaib Khan; Nira Ben-Jonathan; Jiang Wang; Chunying Du
Journal:  J Cancer Sci Ther       Date:  2015-04

Review 4.  Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis.

Authors:  Agata Krawczyk; Joanna Miśkiewicz; Karolina Strzelec; Dominika Wcisło-Dziadecka; Barbara Strzalka-Mrozik
Journal:  Med Sci Monit       Date:  2020-06-22

5.  The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer.

Authors:  Anna Makuch-Kocka; Janusz Kocki; Anna Brzozowska; Jacek Bogucki; Przemysław Kołodziej; Bartosz J Płachno; Anna Bogucka-Kocka
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 6.  Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions.

Authors:  Ömer Güllülü; Stephanie Hehlgans; Claus Rödel; Emmanouil Fokas; Franz Rödel
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.639

7.  BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells.

Authors:  Christopher G Low; Iris S U Luk; Dong Lin; Ladan Fazli; Kuo Yang; Yong Xu; Martin Gleave; Peter W Gout; Yuzhuo Wang
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

8.  The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.

Authors:  Sze Ue Iris Luk; Hui Xue; Hongwei Cheng; Dong Lin; Peter W Gout; Ladan Fazli; Colin C Collins; Martin E Gleave; Yuzhuo Wang
Journal:  Oncotarget       Date:  2014-08-30

9.  Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells.

Authors:  Guangyang Weng; Yingjian Zeng; Jingya Huang; Jiaxin Fan; Kunyuan Guo
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.